We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

0 hedge funds and large institutions have $0 invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1430 (-143)

100% less funds holding in top 10

Funds holding in top 10: 120 (-12)

100% less capital invested

Capital invested by funds: $1.61B → $0 (-$1.61B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
Holders Change
-143
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
142
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
1
Jennison Associates
New York
-$119M -1,589,903 Closed
PAI
2
Palo Alto Investors
California
-$84.4M -1,125,564 Closed
GF
3
Gabelli Funds
New York
-$80.2M -1,069,890 Closed
AA
4
AQR Arbitrage
Connecticut
-$74.8M -997,893 Closed
BFA
5
BlackRock Fund Advisors
California
-$72.4M -965,015 Closed
WIC
6
Water Island Capital
New York
-$67.3M -897,702 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
-$66.8M -891,025 Closed
PCM
8
Pentwater Capital Management
Florida
-$64.5M -860,000 Closed
BM
9
Bridger Management
New York
-$48.1M -641,036 Closed
MF
10
Magnetar Financial
Illinois
-$46.8M -624,547 Closed
OAM
11
Oxford Asset Management
United Kingdom
-$45.1M -601,182 Closed
BIT
12
BlackRock Institutional Trust
California
-$41.7M -556,157 Closed
Deutsche Bank
13
Deutsche Bank
Germany
-$35.6M -474,675 Closed
GLAM
14
Gardner Lewis Asset Management
Pennsylvania
-$35.2M -469,194 Closed
JP Morgan Chase
15
JP Morgan Chase
New York
-$35.2M -468,803 Closed
Morgan Stanley
16
Morgan Stanley
New York
-$32M -426,951 Closed
State Street
17
State Street
Massachusetts
-$30.1M -402,209 Closed
TAL
18
TIG Advisors LLC
New York
-$28.9M -384,824 Closed
GCL
19
Glazer Capital LLC
New York
-$27.5M -366,241 Closed
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
-$24.6M -327,904 Closed
HHC
21
Hutchin Hill Capital
New York
-$21.9M -292,349 Closed
GCIA
22
Gabelli & Co Investment Advisers
New York
-$21.7M -289,545 Closed
PP
23
Paloma Partners
Connecticut
-$20.3M -270,303 Closed
Northern Trust
24
Northern Trust
Illinois
-$20M -266,450 Closed
GI
25
GAMCO Investors
Connecticut
-$19.5M -259,500 Closed

KYTH Hedge Fund Activity: Q4 2015 in Review

0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2015, worth a combined $0 — down 100% from $1.61B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of KYTH and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jennison Associates, exiting entirely with an estimated $119M sold.

  • 0 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2015, down from 143 in Q3 2015.
  • Funds reported $0 of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2015, down 100% quarter-over-quarter.
  • 0 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2015 and 142 closed out, a net change of -142 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2015 was Jennison Associates, an estimated $119M sold.

Based on aggregated 13F filings for Q4 2015.